Importantly, this persistent outlier status was observed across three distinct late stage cancer types: lung, breast, and pancreatic, suggesting pre-diagnosis overexpression of CEACAM5 is not tissue-specific, but rather implicating it with metastasis. The gene discussed is CEACAM5; the disease is cancer.